As a major biomarker of ER-positive BC, ERα and its transcriptional activity are regulated by LSD1 via assembling into complex with different ligands to mediate BC proliferation (Lim et al., 2010; Pollock et al., 2012; Zhu et al., 2012; Andresen et al., 2017). Here, ESR1 is linked to breast cancer.